Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07265596 · ClinicalTrials.gov registry record · Phase 2
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
A Phase 2 study of Prodromal Parkinsons Disease, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 8
- Study locations
NCT07265596 is a Phase 2 study of Prodromal Parkinsons Disease that is actively recruiting participants, run by Michael J. Fox Foundation for Parkinson's Research. The registered enrollment target is 100 participants. The trial reports 8 study locations across 7 states.
The verdict
NCT07265596, a Phase 2 study of Prodromal Parkinsons Disease, is actively recruiting participants, sponsored by Michael J. Fox Foundation for Parkinson's Research.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 8
- Study locations
Study Summary
The study is a longitudinal, multi-center study to assess progression of \[18F\] AV-133 imaging in Prodromal PD participants. Participants will be followed for up to 24 months. Approximately 100 Prodromal participants will be recruited from up to 10 sites. Participants will be comprehensively assessed at baseline and follow up. Participants will undergo imaging assessments with \[18F\] AV-133 and clinical (motor, neuropsychiatric, cognitive and imaging and biomarker) assessments (conducted under the PPMI Clinical protocol).
Conditions Studied
Interventions
- DRUG [18F] AV-133 PET Imaging
Study Locations (8)
Other
- Philipps-University of Marburg - Hessen
- Tel Aviv Sourasky Medical Center - Tel Aviv
Connecticut
- Institute for Neurodegenerative Disorders - New Haven
Pennsylvania
- University of Pennsylvania - Philadelphia
Ontario
- Toronto Western Hospital - Toronto
Gelderland
- Radboud University - Nijmegen
Britain
- Queen Mary University of London - London
Tyne and Wear
- Newcastle University - Newcastle upon Tyne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-10-30 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07265596
The ClinicalTrials.gov registry entry for NCT07265596 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael J. Fox Foundation for Parkinson's Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prodromal Parkinsons Disease appearing as the primary indexed condition, and to 1 intervention - of which [18F] AV-133 PET Imaging is the first listed.
NCT07265596 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Other, Connecticut, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07265596 about?
NCT07265596 is a clinical study titled "Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)". The study is a longitudinal, multi-center study to assess progression of \[18F\] AV-133 imaging in Prodromal PD participants. Participants will be followed for up to 24 months. Approximately 100 Prodromal participants will be recruited from up to 10 sites. Participants will be comprehensively assess...
What is the current status of trial NCT07265596?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2023-10-30. Estimated completion is 2027-12.
What conditions does trial NCT07265596 study?
This clinical trial studies the following conditions: Prodromal Parkinsons Disease.
What interventions are being tested in trial NCT07265596?
The interventions under investigation include: [18F] AV-133 PET Imaging (DRUG).
Who is sponsoring clinical trial NCT07265596?
This trial is sponsored by Michael J. Fox Foundation for Parkinson's Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07265596 being conducted?
This trial has 8 study locations across Connecticut, Pennsylvania, Ontario, Gelderland, Britain. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.